The American College of Cardiology (ACC) and the American Heart Association (AHA) are two of the leading medical organizations that have developed new recommendations for managing and preventing ...

New Orleans-based Ochsner Health has become the first provider in Louisiana to offer an artificial intelligence-powered technology for treating atrial fibrillation. The system’s John Ochsner Heart and ...

Atrial fibrillation (AFib) is the most prevalent form of cardiac arrhythmia, affecting a significant portion of the global population. Often marked by irregular and rapid heartbeats, AFib presents a ...

Despite being the most common form of cardiac arrhythmia, atrial fibrillation (AFib) is a condition that often goes undiagnosed and/or untreated. The condition, which often accompanies other health ...

In the U.S., the incidence of atrial fibrillation, the most common arrhythmia in the world, has more than doubled since 2010, increasing from 5 million to 10.5 million. Each year, 250,000 new cases ...

About 1 in 3 people with atrial fibrillation — the most common type of heart rhythm disorder — do not know they have the condition, which is problematic considering it increases the risk of stroke, ...

Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...

UAB Division of Cardiothoracic Surgery Assistant Professor Panayotis Vardas, M.D., has co-authored the article, "The Society of Thoracic Surgeons 2023 clinical practice guidelines for the surgical ...

A major clinical trial has found Boston Scientific’s Farapulse pulsed-field ablation nearly doubles the success rate of treating persistent atrial fibrillation compared with medication. One year after ...

If you sometimes experience a racing or irregular heartbeat, it may be caused by atrial fibrillation (AFib), the most common type of heart arrhythmia. AFib can make you five times more likely to have ...

A major international trial has found that pulsed-field catheter ablation offers superior outcomes to antiarrhythmic drugs for patients with persistent atrial fibrillation. One year after treatment, ...